Table 5.
Random-effects meta-analysis for the association between a increase in exposure to particulate matter with an aerodynamic diameter below () and breast cancer onset: main analyses, sensitivity analyses (SA, based on the main analysis not corrected for publication bias), and supplementary analyses according to the menopausal status or the hormonal receptor subtype.
Meta-analysis | effect estimates | cases | participants | RR (95% CI) | (%) | Heterogeneity -valuea |
---|---|---|---|---|---|---|
Main analysis (not corrected for publication bias)b | 13 | 23,765 | 1,326,524 | 1.058 (0.994, 1.126) | 27.6 | 0.14 |
Main analysis (corrected for publication bias)b | 16 | 24,228c | 1,337,704c | 1.047 (0.984, 1.113) | 27.5 | 0.13 |
SA1. Leave-one-out meta-analysisd | 12 | 14,188 | 305,492 | 1.023 (0.975, 1.073) | 3.9 | 0.69 |
SA2. Restricted to prospective cohort studies | 11 | 13,023 | 303,056 | 1.023 (0.971, 1.078) | 7.6 | 0.61 |
SA3. Restricted to European populations | 10 | 14,800 | 1,105,581 | 1.119 (0.998, 1.254) | 14.9 | 0.43 |
SA4. Restricted to North American populations | 3 | 8,965 | 220,943 | 1.017 (0.973, 1.062) | 0.0 | 0.74 |
SA5. Restricted to studies with adjustment for main reproductive factorse | 4 | 8,455 | 198,823 | 1.019 (0.964, 1.078) | 0.0 | 0.84 |
SA6. Restricted to studies with adjustment for socioeconomic contextf | 10 | 11,878 | 280,179 | 1.023 (0.965, 1.085) | 11.6 | 0.53 |
SA7. Restricted to effect estimates reported in “all women” onlyg | 6 | 20,852 | 1,267,288 | 1.058 (0.990, 1.131) | 48.1 | 0.079 |
SA8. Excluding CECILE case–control study (not published yet) | 12 | 22,600 | 1,324,088 | 1.058 (0.991, 1.130) | 33.0 | 0.10 |
SA9. Restricted to studies with exposure assessment based on precise home addressesh | 12 | 14,188 | 305,492 | 1.023 (0.975, 1.073) | 3.9 | 0.69 |
SA10. Restricted to studies with exposure assessment based on residential historyi | 4 | 8,455 | 198,823 | 1.019 (0.964, 1.078) | 0.0 | 0.84 |
SA11. Restricted to studies with exposure assessment based on modeling dataj | 11 | 17,620 | 1,153,014 | 1.084 (0.987, 1.192) | 24.0 | 0.15 |
SA12. Restricted to studies with recruitment starting in 2000 or latek | 4 | 13,630 | 1,072,832 | 1.129 (0.929, 1.373) | 49.2 | 0.033 |
In premenopausal women | 3 | 2,849 | NAl | 0.992 (0.894, 1.100) | 4.7 | 0.37 |
In postmenopausal women | 10 | 6,692 | NAl | 1.013 (0.932, 1.102) | 9.6 | 0.53 |
Hormone responsive positive () | 4 | 5,917 | NAl | 1.012 (0.955, 1.072) | 0.0 | 0.75 |
Hormone responsive negative () | 4 | 1,338 | NAl | 0.991 (0.807, 1.217) | 39.4 | 0.13 |
Note: Studies included in sensitivity analyses (SA): SA1: All but AOK PLUS; SA2: CEANS, DCH, DNC, EPIC-NL, EPIC-Oxford, EPIC-Turin, HUBRO, MEC, NHSII, Sister Study, VHM&PP; SA3: AOK PLUS, CEANS, CECILE, DCH, DNC, EPIC-NL, EPIC-Oxford, EPIC-Turin, HUBRO, VHM&PP; SA4: MEC, NHSII, Sister Study; SA5: CECILE, DNC, MEC, NHSII; SA6: CEANS, DCH, EPIC-NL, EPIC-Oxford, EPIC-Turin, HUBRO, MEC, NHSII, Sister Study, VHM&PP; SA7: AOK PLUS, CECILE, DNC, MEC, NHSII, Sister Study; SA8: All but CECILE; SA9: CEANS, CECILE, DCH, DNC, EPIC-NL, EPIC-Oxford, EPIC-Turin, HUBRO, MEC, NHSII, Sister Study, VHM&PP; SA10: CECILE, DNC, MEC, NHSII; SA11: AOK PLUS, CEANS, CECILE, DCH, DNC, EPIC-NL, EPIC-Oxford, EPIC-Turin, HUBRO, Sister Study, VHM&PP; SA12: AOK PLUS, CECILE, HUBRO, Sister Study; In premenopausal women: CECILE, NHSII, Sister Study; In postmenopausal women: CEANS, CECILE, DCH, EPIC-NL, EPIC-Oxford, EPIC-Turin, HUBRO, NHSII, Sister Study, VHM&PP; On hormonal receptor subtypes: CECILE, MEC, NHSII, Sister Study. CI: confidence interval: .
Cochrane’s heterogeneity Q test.
Effect estimates reported in studies led in postmenopausal women only were included in the main meta-analysis in addition to the effect estimates reported in “all women” (i.e., irrespective of menopausal status).
Effectives simulated by trim-and-fill analysis.
I.e., excluding the study contributing the most to the between-study heterogeneity (Figure S3).
Age at menarche, age at the first full-term pregnancy, and parity.
At the area level.
I.e., irrespective of menopausal status.
I.e., excluding studies in which air pollutant levels were assessed at the postal code scale.
I.e., excluding studies in which air pollutant levels were assessed for a single home address.
I.e., from land-use regression (LUR), dispersion model (DM), or chemistry-transport model (CTM).
Because of stronger potential for exposure misclassification in studies recruiting subjects before 2000.
Sample size could not be calculated due to missing information in source studies.